Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Journal of Chemotherapy (Florence, Italy)
|
December 3, 2020
Prognostic factors and effect on survival of immune-related adverse events in patients with non-small-cell lung cancer treated with immune checkpoint blockage
David Conde-Estévez, Inés Monge-Escartín, Alejandro Ríos-Hoyo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 17, 2025
First-line osimertinib compared to earlier generation TKIs in advanced EGFR-mutant NSCLC: A real-world survival analysis
Igor Gomez-Randulfe, Lauren A Scanlon, Mathew Carter, et al.
EJNMMI Physics
|
August 22, 2024
Design and proof of concept of a double-panel TOF-PET system
Andrea Gonzalez-Montoro, Noriel Pavón, Julio Barberá, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Comparison of Different Methods for Defining Hyperprogressive Disease in NSCLC
Pedro Rocha, Didac Ramal, Enric Ripoll, et al.
EJNMMI Physics
|
June 7, 2020
Pilot performance of a dedicated prostate PET suitable for diagnosis and biopsy guidance
Gabriel Cañizares, Andrea Gonzalez-Montoro, Marta Freire, et al.
Physics in Medicine and Biology
|
June 25, 2025
NEMA NU 4-2008 performance and MRI-compatibility study of the edgeless preclinical PET insert: ScintoTube
Andrea González Montoro, Marta Freire, Fernando López-Berenguer, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 1, 2023
Pre-existing tumor host immunity characterization in resected non-small cell lung cancer
Pedro Rocha, Maite Rodrigo, Laura Moliner, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 20, 2024
An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer
Ilias Houda, Idris Bahce, Chris Dickhoff, et al.
Oncoimmunology
|
February 24, 2025
Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockade
Pedro Rocha, Rafael Bach, Laura Masfarré, et al.
JTO Clinical and Research Reports
|
January 13, 2025
First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study
Laura Moliner, Núria Zellweger, Sabine Schmid, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Journal of Chemotherapy (Florence, Italy)
|
December 3, 2020
Prognostic factors and effect on survival of immune-related adverse events in patients with non-small-cell lung cancer treated with immune checkpoint blockage
David Conde-Estévez, Inés Monge-Escartín, Alejandro Ríos-Hoyo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 17, 2025
First-line osimertinib compared to earlier generation TKIs in advanced EGFR-mutant NSCLC: A real-world survival analysis
Igor Gomez-Randulfe, Lauren A Scanlon, Mathew Carter, et al.
EJNMMI Physics
|
August 22, 2024
Design and proof of concept of a double-panel TOF-PET system
Andrea Gonzalez-Montoro, Noriel Pavón, Julio Barberá, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Comparison of Different Methods for Defining Hyperprogressive Disease in NSCLC
Pedro Rocha, Didac Ramal, Enric Ripoll, et al.
EJNMMI Physics
|
June 7, 2020
Pilot performance of a dedicated prostate PET suitable for diagnosis and biopsy guidance
Gabriel Cañizares, Andrea Gonzalez-Montoro, Marta Freire, et al.
Physics in Medicine and Biology
|
June 25, 2025
NEMA NU 4-2008 performance and MRI-compatibility study of the edgeless preclinical PET insert: ScintoTube
Andrea González Montoro, Marta Freire, Fernando López-Berenguer, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 1, 2023
Pre-existing tumor host immunity characterization in resected non-small cell lung cancer
Pedro Rocha, Maite Rodrigo, Laura Moliner, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 20, 2024
An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer
Ilias Houda, Idris Bahce, Chris Dickhoff, et al.
Oncoimmunology
|
February 24, 2025
Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockade
Pedro Rocha, Rafael Bach, Laura Masfarré, et al.
JTO Clinical and Research Reports
|
January 13, 2025
First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study
Laura Moliner, Núria Zellweger, Sabine Schmid, et al.
Page
of 3